|
TMEM179B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.540500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.800100E-03 |
| Normal-vs-Stage2 |
3.228200E-01 |
| Normal-vs-Stage3 |
7.770600E-01 |
| Normal-vs-Stage4 |
9.746200E-01 |
| Stage1-vs-Stage2 |
5.017200E-01 |
| Stage1-vs-Stage3 |
7.943500E-03 |
| Stage1-vs-Stage4 |
8.357700E-02 |
| Stage2-vs-Stage3 |
2.392400E-01 |
| Stage2-vs-Stage4 |
4.327000E-01 |
| Stage3-vs-Stage4 |
8.154400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.829600E-02 |
| Normal-vs-AfricanAmerican |
2.496000E-01 |
| Normal-vs-Asian |
4.208000E-02 |
| Caucasian-vs-AfricanAmerican |
4.904000E-02 |
| Caucasian-vs-Asian |
3.378400E-01 |
| AfricanAmerican-vs-Asian |
2.091600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.754850E-01 |
| Normal-vs-Female |
6.276400E-02 |
| Male-vs-Female |
9.177400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.302100E-03 |
| Normal-vs-Age(41-60Yrs) |
9.020000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.957200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.153000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.181200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.301700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.477600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.183200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.351600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.998100E-03 |
| Classical-VS-Follicular |
6.714200E-01 |
| Classical-VS-Other |
7.868200E-01 |
| Classical-VS-Normal |
2.092100E-02 |
| Tall-VS-Follicular |
2.137700E-02 |
| Tall-VS-Other |
7.349800E-02 |
| Tall-VS-Normal |
9.565600E-02 |
| Follicular-VS-Other |
7.168400E-01 |
| Follicular-VS-Normal |
2.416400E-01 |
| Other-VS-Normal |
1.480370E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.584300E-02 |
| Normal-vs-N1 |
7.402400E-01 |
| N0-vs-N1 |
2.490600E-01 |
|
|
